FDA approval of the world’s first gene therapy for Haemophilia
We are incredibly proud to announce the FDA approval of the world’s first #genetherapy for #hemophiliaB. https://lnkd.in/e4SFzMCc
Noticias
Noticias relacionadas con terapia génica y celular.
- Jun 8
SETGYC 2022 Oral and Poster Award Winners
Congratulations to this year's oral and poster award winners, who presented at the SETGYC Biennial Congress in Sevilla.
- May 13
Outreach opportunity as a translator for EuroGCT
EuroGCT is seeking volunteer scientists who are native speakers of Spanish or other languages to translate gene and cell therapy information
- May 4
In memory of Dr. Manfred Schmidt
SETGYC would like to express our sadness and dismay at the loss of Dr. Manfred Schmidt.
- Dec 20, 2021
SETGYC Navidad 2021 | El mejor regalo
SETGYC | Esta Navidad, vosotros nos habéis dado el mejor regalo
- Dec 17, 2021
In memoriam Juan Carlos Ramirez
La Junta Directiva de la SETGyC manifiesta su consternación por el fallecimiento del Dr. Juan C. Ramírez.
- Nov 12, 2020
Educational Resource: New Horizons in the Management of ADA-SCID
New Horizons in the Management of ADA-SCID is a free educational resource for healthcare professionals managing patients with this rare...
- Jun 25, 2020
Academia developing medicines for rare diseases to receive free EMA scientific advice
The academic sector plays an important role in the development of innovative medicines. Their scientific research is often at the source...
- Jun 18, 2020
VIVEbiotech collaborates with Xyphos Biosciences for clinical development support...
VIVEbiotech collaborates with Xyphos Biosciences for clinical development support of convertible CAR-T™ cell therapy Press release...